These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
102 related articles for article (PubMed ID: 263195)
21. FDA insists that oestrogen products for menopause carry a warning. Gottlieb S BMJ; 2003 Jan; 326(7381):126. PubMed ID: 12531839 [No Abstract] [Full Text] [Related]
22. Mandatory PPIs to begin in 1981; APhA issues strong objections. Small WE Am Pharm; 1980 Nov; NS20(11):10-1. PubMed ID: 7457342 [No Abstract] [Full Text] [Related]
23. The status of unit-of-use in Europe and the United States: an evolution in drug dispensing. Archambault GF Hosp Formul; 1979 Jan; 14(1):70-1, 75-6, 78-9. PubMed ID: 10297341 [No Abstract] [Full Text] [Related]
24. On narrowing the patient-doctor communications gap. FDA Consum; 1982 May; 16(4):19-21. PubMed ID: 10309635 [No Abstract] [Full Text] [Related]
25. Teen suicide pills? An FDA panel calls for tough labels on antidepressants. What it means for you. Gorman C Time; 2004 Sep; 164(13):77. PubMed ID: 15478737 [No Abstract] [Full Text] [Related]
26. Informing women about 'The Pill'. FDA Consum; 1977 Feb; 11(1):20-1. PubMed ID: 10304983 [No Abstract] [Full Text] [Related]
28. Assessment and reporting of clinical pharmacology information in drug labeling. Spyker DA; Harvey ED; Harvey BE; Harvey AM; Rumack BH; Peck CC; Atkinson AJ; Woosley RL; Abernethy DR; Cantilena LR Clin Pharmacol Ther; 2000 Mar; 67(3):196-200. PubMed ID: 10741621 [No Abstract] [Full Text] [Related]
29. Patient package inserts: a research perspective. Morris LA; Groft SC Drug Ther; 1982; ():191-217. PubMed ID: 7105993 [No Abstract] [Full Text] [Related]
30. Patient package inserts: goals versus achievements. Lasagna L Drug Ther; 1982; ():181-9. PubMed ID: 7105992 [No Abstract] [Full Text] [Related]
31. Increasing the odds of patient compliance through prescription warning labels. Ferguson JM; Discenza R; Miller JA J Health Care Mark; 1987 Mar; 7(1):37-46. PubMed ID: 10281382 [TBL] [Abstract][Full Text] [Related]
32. Current FDA directives for promoting public health. Hayes AH Am J Hosp Pharm; 1982 Mar; 39(3):427-31. PubMed ID: 7072727 [TBL] [Abstract][Full Text] [Related]
33. The patient package insert and its legal implications. Cook D Leg Med Q; 1980; 4():258-70. PubMed ID: 10258797 [No Abstract] [Full Text] [Related]
34. Patient package inserts: the proper prescription? Rowe HM Food Drug Law J; 1995; 50(1):95-124. PubMed ID: 10342988 [No Abstract] [Full Text] [Related]
35. Informing patients about drugs: a wrong way and a right way. Woodson DW Med World News; 1979 Jun; 20(13):6. PubMed ID: 10242286 [No Abstract] [Full Text] [Related]
36. New OTC drug facts label. FDA Consum; 2002; 36(4):35. PubMed ID: 12184303 [No Abstract] [Full Text] [Related]
37. Current good manufacturing practice in manufacturing, processing, packing, or holding of drugs; revision of certain labeling controls--FDA. Final rule. Fed Regist; 1993 Aug; 58(147):41348-54. PubMed ID: 10127711 [TBL] [Abstract][Full Text] [Related]